Proteus Biomedical Inc Product Pipeline Analysis

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Physician Views: Biosimilar Lucentis - what opportunity?

Physician Views: Biosimilar Lucentis - what opportunity?

  • $ 645
  • Industry report
  • by Firstword Pharma
  • October 2014

With the initial focus of biosimilar antibody developers very much sharpened on the markets for TNF inhibitors (Remicade, Humira) and leading cancer MAbs (Herceptin, Rituxan, Avastin), the opportunity for biosimilar Lucentis, for the treatment of wet age-related macular degeneration (AMD) has been ...

Industries: Biopharmaceutical | Countries: United States

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

Abnova Corporation (Symbol:4133) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Abnova Corporation SWOT Analysis report provides you a strategic analysis ...

Industries: Biopharmaceutical | Countries: United States, Taiwan, Japan

biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

biOasis Technologies Inc. (Symbol:BTI) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. biOasis Technologies Inc. SWOT Analysis report provides you a strategic ...

Industries: Biopharmaceutical | Countries: United States, Canada, United Kingdom

BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

BioMedical Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Biopharmaceutical | Countries: United States

Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

Calypte Biomedical Corporation (Symbol:CBMC) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Calypte Biomedical Corporation SWOT Analysis report provides you a ...

Industries: Biopharmaceutical | Countries: United States

FFF Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

FFF Enterprises, Inc. SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Biopharmaceutical | Countries: United States

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

Innate Pharma SA (Symbol:IPH) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Innate Pharma SA SWOT Analysis report provides you a strategic analysis ...

Industries: Biopharmaceutical | Countries: United States

Omeros Corporation (Symbol:OMER) SWOT Analysis, Strategy, Revenues and Profits

Omeros Corporation (Symbol:OMER) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Omeros Corporation SWOT Analysis report provides you a strategic analysis ...

Industries: Biopharmaceutical | Countries: United States

Pall Biomedical Inc SWOT Analysis, Strategy, Revenues and Profits

Pall Biomedical Inc SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Biopharmaceutical | Countries: United States

Peregrine Pharmaceuticals, Inc. (Symbol:PPHM) SWOT Analysis, Strategy, Revenues and Profits

Peregrine Pharmaceuticals, Inc. (Symbol:PPHM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • October 2014
  • 25 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. Peregrine Pharmaceuticals, Inc. SWOT Analysis report provides you ...

Industries: Biopharmaceutical | Countries: United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.